Health Care: Drugs

Albany Molecular Research Inc (AMRI: NASDAQ)

$17.33 0.09 | 0.52%
12/07/16 - 04:00 PM ET
Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) -2.30M -3.28M 11.77M -4.26M
Operating Gains/Losses 118.00K -1.12M 234.00K 176.00K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -10.52M -10.20M -9.33M -13.57M
(Increase) Decrease in Inventories 7.73M -7.97M -5.14M -3.58M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 6.82M -4.87M 7.70M 196.00K
(Decrease) Increase In Other Current Liabilities -4.92M -5.84M 4.50M 5.04M
(Increase) Decrease In Other Working Capital 1.04M 1.05M -2.60M -1.25M
Other Non-Cash Items 9.24M 11.39M 3.98M 10.42M
Net Cash From Continuing Operations 39.63M 1.91M 28.18M 15.34M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 39.63M 1.91M 28.18M 15.34M
Sale of Property, Plant & Equipment 31.00K 80.00K 300.00K 447.00K
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 213.00K
Purchases of Property, Plant & Equipment -22.17M -17.59M -11.55M -10.44M
Acquisitions -199.58M -145.75M 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -221.72M -163.26M -11.25M -9.78M
Issuance of Debt 269.66M 35.00M 150.00M 5.00M
Cash Used for Financing Activities
Issuance of Capital Stock 3.46M 2.31M 24.63M 531.00K
Repayment of Long-Term Debt -81.86M -5.06M -34.38M -2.84M
Repurchase of Capital Stock -824.00K -579.00K -164.00K 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -5.01M 1.57M -3.20M -5.23M
Net Cash From Financing Activities 185.42M 33.24M 136.88M -2.53M
Effect of Exchange Rate Changes -980.00K -820.00K -1.18M 288.00K
Net Change in Cash & Cash Equivalents 2.35M -128.93M 152.63M 3.31M

Portfolios with AMRI

Latest AMRI Headlines from TheStreet

More Financial News for AMRI

Press Releases for AMRI

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter